SELLAS Life Sciences (SLS) Gross Margin (2012 - 2022)

SELLAS Life Sciences' (SLS) quarterly Gross Margin came in at 90.0% in Q1 2022, down 825.0% year-on-year from 12.41% in Q1 2021, and down 5.0% on a QoQ basis from 94.74% in Q2 2021.

SELLAS Life Sciences (SLS) Gross Margin (2012 - 2022) Analysis & Trends

SELLAS Life Sciences (SLS) has 7 years of Gross Margin data on file, last reported at 90.0% in Q1 2022.

  • On a quarterly basis, Gross Margin fell 825.0% year-over-year to 90.0% in Q1 2022; TTM through Dec 2022 was 90.0%, a 737.0% decrease from a year earlier, with the FY2022 full-year figure at 90.0%, down 737.0% from the prior year.
  • Gross Margin for Q1 2022 stood at 90.0%, down from 94.74% in the prior quarter.
  • Over the last five years, Gross Margin for SLS reached as high as 100.0% in Q4 2020 and fell as low as 90.0% in Q1 2022.
  • Historically, Gross Margin has averaged 95.75% across 3 years, with a median of 96.49% in 2021.
  • On a YoY basis, Gross Margin climbed as much as 825 bps in 2022 and fell as far as 825 bps in 2022.
  • Year by year, Gross Margin stood at 100.0% in 2020, then retreated by 5 bps to 94.74% in 2021, then retreated by 5 bps to 90.0% in 2022.
  • Per Business Quant data, the three most recent Gross Margin figures were 90.0% in Q1 2022, 94.74% in Q2 2021, and 98.25% in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 88.95%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 91.79%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 90.68%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 SELLAS Life Sciences 1.96 Bn 1.96 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 90.00%
Jun 30, 2021 94.74%
Mar 31, 2021 98.25%
Dec 31, 2020 100.00%
Jun 30, 2015 86.16%
Mar 31, 2015 85.71%
Dec 31, 2014 85.04%
Sep 30, 2014 84.75%
Jun 30, 2014 85.11%
Mar 31, 2014 84.77%
Dec 31, 2013 91.80%
Sep 30, 2013 53.64%
Jun 30, 2013 100.00%
Mar 31, 2013 100.00%
Dec 31, 2012 100.00%